Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07405983Not Yet Recruiting

TOUCH® CMC 1 New Enrollment US Study

Role: lead

NCT06546306Active Not Recruiting

Post Market Clinical Follow-Up TOUCH® CMC 1

Role: lead

NCT06546345Recruiting

Post Market Clinical Follow-Up KeriFlex®

Role: lead

NCT06546332Active Not Recruiting

Post Market Clinical Follow-Up KeriFuse®

Role: lead

All 4 trials loaded